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Abstract This paper reports a novel medication release and
delivery mechanism as part of a next generation wireless cap-
sule endoscope (WCE) for targeted drug delivery. This sub-
system occupies a volume of only 17.9mm3 for the purpose of
delivering a 1 ml payload to a target site of interest in the small
intestinal tract. An in-depth analysis of the method employed
to release and deliver the medication is described and a series
of experiments is presented which validates the drug delivery
system. The results show that a variable pitch conical com-
pression spring manufactured from stainless steel can deliver
0.59 N when it is fully compressed and that this would be
sufficient force to deliver the onboard medication.
Keywords Biomedical robotics . Gastrointestinal (GI) tract .
Capsule endoscopy . Targeted therapy .Microrobot .Wireless
capsule endoscopy
1 Introduction
Endoscopes and colonoscopies are used routinely by gastro-
enterologists to diagnose and treat pathologies such as
Crohn’s disease in the gastrointestinal (GI) tract. However
the small intestine poses a problem for these conventional
methods as it is very difficult to access. One method employed
to overcome this problem is the use of wireless capsule endo-
scopes (WCE). These pill-sized cameras take pictures of the
intestinal wall which are then used to diagnose pathologies.
The market leader in WCE is Given Imaging Ltd. [1] who in
2000 specifically designed the M2 A to examine the small
intestinal tract through natural peristaltic pressure. The
11.0 mm in diameter X 25.0 mm long pill contains a
CMOS-based image sensor to take pictures of the intestinal
wall. The pictures can be transmitted to a device worn by the
patient for later evaluation. A detailed review of WCE
is reported in [2].
The problem with current WCE devices is that they do not
offer the ability to administer therapy to an affected area of the
GI tract. However there is a clinical need to target and treat
these pathologies [3] hence endeavours have been made by
researchers to perform regional drug absorption services.
These systems are capable of delivering up to 1 ml of medi-
cation to a region of the GI tract such as the jejunum, ileum,
ascending colon or descending colon either through the pro-
gressive release of medication over a period of time or through
releasing in a bolus form. However the delivery methods
employed by these devices prevent the direct targeting of spe-
cific pathogens such as tumours or ulcers as the medication is
spread over a section of lumen due to the constant movement
from peristalsis, further they have no means of stopping and
holding their position.
1.1 State of the art
The focus of conventional passive WCE medical devices has
been to take pictures of the GI tract however the next gener-
ation of WCE must possess additional functionality to enable
them to carry out useful tasks such as performing a biopsy or
targeted drug delivery [4]. To facilitate this additional func-
tionality active mechanical parts will be required to perform
the tasks such as resisting natural peristalsis.
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1.1.1 Resisting peristalsis
The limitations of conventional WCE have led researchers to
explore methods of increasing a capsule’s functionality such
as the ability to navigate through the GI tract [3–5] or resist
natural peristalsis [6–10]. The paddling based microrobot de-
veloped by Park et al. (2007) [11] was developed specifically
for navigating the GI tract. This method of locomotion uses a
leadscrew engaged with six radially positioned legs to propel a
microrobot forwards. A three-legged anchoring mechanism
which utilises micropatterned adhesives for resisting peristal-
sis is proposed by Glass et al. (2008) [12]. This method of
anchoring to the intestinal wall reduces the risk of injury to the
intestinal tissue.
Menciassi et al. (2005) [13] propose a clamping system
utilising three grasping units which extend forwards from
the capsule and are driven by thermally activating a 100 μm
diameter SMA for the purpose of clamping to the wall of the
GI tract to monitor pH levels long-term.
A major limitation of commercial WCEs is the lack of
control over their speed and direction of travel as they rely
on the natural movement from peristalsis to progress through
the GI tract. A potential solution to this issue is the robotic
legged locomotion device developed by Valdastri et al. (2009)
[14]. The 12-legged endoscopic capsular microrobot utilises
two sets of six legs which are integrated into the capsule. The
legs allow the capsule to navigate through the GI tract and
allow for better visualisation due to the legs uniformly
distending the collapsed colon tissue.
Inspecting the lining of the oesophagus is routinely per-
formed using a flexible endoscope however this procedure
results in discomfort for the patient. An approach proposed
by Tognarellia et al. (2009) [15] utilises three equally spaced
SMA flaps incorporated into an 11 mm in diameter by 31 mm
long capsule to rapidly halt the progress of an oesophageal
WCE for the purpose of inspecting the oesophagus lining.
1.1.2 Drug delivery
Phaeton Research has developed the Enterion capsule [16] for
the purpose of delivering drugs to a specific location in the GI
tract. The 11 mm in diameter by 32 mm long capsule has an
onboard drug reservoir capable of holding 1 ml of medication
in either a liquid, powder or solid form. The capsule relies on
natural peristalsis to progress through the alimentary canal.
Tracking the capsule’s position through the GI tract is by
means of a gamma-emitting radionuclide placed inside the
capsule and a gamma camera. Once a target site has been
located the medication is ejected through the release of a com-
pressed spring which operates a piston that pushes the medi-
cation out of a port at the rear of the capsule.
The InteliSite capsule manufactured by Innovative Devices
LLC [17] delivers 1 ml of medication in either a liquid or a
powder drug form through side ports which are activated
when the capsule is exposed to a radio frequency magnetic
field. The magnetic field causes two SMA wires which are
connected to a sleeve to heat up and straighten out resulting
in the sleeve rotating and aligning the side ports to release the
medication. The 10 mm diameter by 32 mm long capsule
disperses the medication by virtue of the turbulence created
by the capsule travelling through the GI tract.
The IntelliCap is an intelligent pill developed by Philips
Research [18] to electronically control the release of drugs
into the GI tract. The 11 mm diameter by 26 mm long pill
integrates a drug reservoir, battery, temperature sensor, pH
sensor, RF wireless transceiver, fluid pump and microproces-
sor. The microprocessor controls the release of medication
through the fluid pump which allows the medication to be
released in either a burst, progressive release or a multi-
location dosing form.
Karargyris et al. (2015) [19] propose the OdoCapsule
which provides video stability and positional information
while navigating the GI tract. The system, which is based on
previous work carried out by Bourbakis et al. (2010) [20],
utilises three positional sensor wheels as opposed to the one
wheel approach proposed by Lambert et al. (1991) [21]. The
capsule’s three sensor wheels are mounted on 15 mm long
legs which protrude out of the 13 mm diameter by 30 mm
long capsule by 35° due to torsion springs. The wheels contact
the GI tract wall and each rotation of the wheel is recorded to
monitor the progress of the capsule.
1.1.3 Localization
It is of great benefit to know the position and orientation of the
WCE when it is travelling through the GI tract [22] as the 3D
positional data can be used to return to a site of interest to
perform further diagnosis or to administer therapy. The me-
chanical method of employing wheels proposed by Lambert
et al. [21] and Karargyris et al. [19] may offer a potential
solution however relocating the site of a previously captured
image, in relation to the position and orientation of the cap-
sule, is still a challenge to achieve. Further the unrestrained,
slippery, compliant environment of the small intestine adds
greater complexity to the problem. Therefore alternative
methods of tracking a capsule’s position which do not use a
mechanical means of interaction with the GI tract wall have
been proposed by researchers.
The InteliSite capsule [17] can be tracked through the GI
tract using gamma scintigraphy which will detect Indium (111
In) or Technetium (99 mTc) gamma isotopes which have been
incorporated into the capsule. This method of localization is
limited as only the capsule’s general position can be
determined.
The position of the M2 A by Given Imaging [1] is deter-
mined by monitoring electromagnetic waves transmitted to
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eight external receivers [23]. TheM2 A utilises radio frequen-
cy triangulation to monitor the signal strength of the transmit-
ted images to monitor the progress of the capsule through the
GI tract. This method is restricted to 2D positioning and a
positional error of 37.7 mm [24].
A promising method to monitor the movements of a WCE
through the GI tract is through the magnetic field strength of
an onboard permanent magnet [23]. Magnetoresistive sensors
attached to the skin allow the orientation and position of the
WCE to be approximated with average positional errors of
3.3 mm reported [25].
1.2 Research aim
The aim of this research is to increase the capability of passive
capsules by increasing their functionality, specifically to
achieve targeted drug delivery in the GI tract. Our previous
work focused on developing a mechanism to resist natural
peristalsis and also to target specific locations in the GI tract.
A novel biologically-inspired holding mechanism was pro-
posed which is based on the order of insects known as
Coleopterans (beetles). Coleopterans have two pairs of wings
and include insects such as the coccinellidae (ladybird). The
ladybird has the ability to fold away its wings behind a second
hardened pair of wings which are used as a casing to protect
them. Using the concept of a pair of folded wings protected by
an outer case as a basic premise, a compact holding mecha-
nism was prototyped from Nylon 6 and incorporated into a
WCE for the purpose of resisting natural peristalsis in the GI
tract [26]. To further increase the functionality of WCE a
novel targeting mechanism was proposed which can be incor-
porated into a WCE for the purpose of delivering a metered
dose of medication to a targeted site of interest in the small
intestinal tract. A fully functioning prototype targeting mech-
anism was presented which is capable of positioning a needle
within a 360 degree envelope [27].
This paper presents the final mechanism required for
targeted drug delivery in the GI tract. A method of delivering
medication from the microrobot’s onboard reservoir to a site
of interest in the small intestinal tract is presented which, com-
bined with the holding mechanism and targeting mechanism,
results in a microrobot with sufficient functionality to deliver a
metered dose of medication to a target site in the GI tract. The
paper is organised as follows: Section 2 introduces the concept
design, Section 3 describes the drug delivery system,
Section 4 presents validation of the drug delivery system
through experimentation and Section 5 concludes this work.
2 Concept design
The clinical need to treat pathologies of the GI tract are not being
met by today’s technology. Currently pathologies such as
Crohn’s disease and ulcerative colitis are being treated by con-
ventional endoscopes in the lower section of the alimentary canal
however the middle section of the GI tract, the ilium and jeju-
num, can only be accessed by the application of a WCE. Images
transmitted from a WCE are reviewed to diagnosis pathologies
however these passive devices are limited as they are not capable
of administering curative treatments. Figure 1 shows a concept
design of a microrobot with integrated systems to facilitate
targeted drug delivery in the GI tract.
Figure 1 shows a microrobot concept design capable of
resisting natural peristalsis through the deployment of a hold-
ing mechanism, targeting a pathology of the GI tract and de-
livering a 1 ml dose of medication to the site of interest
through the positioning of a needle. The needle has the ability
to be positioned in a 360 degree envelope while simultaneous-
ly maintaining a diametrically opposite relationship with the
holding mechanism, this novel feature guarantees needle pen-
etration of the GI tract wall.
The holding mechanism in Fig. 2 uses a single micromotor
manufactured by Faulhaber to open and close two legs. The two
legs are connected to a central support via two pinned leg ties.
The two-legged design utilizes a micromotor, which is orientated
in a vertical position. The micromotor is connected to a bevel
gear set, which allows the micromotor’s rotation to be translated
through 90 degrees. The bevel gear drives a gear train of spur
gears which drive the legs in and out. This novel configuration
reduces the micromotor’s revolution per minute (RPM). The
reduction in RPM will result in a multiplication of the
micromotor’s torque; this will give the legs the strength required
to distend the GI tract wall and hold the microrobot in place. A
detailed evaluation of the holding mechanism can be found in
[26].
Delivering a metered dose of medication to a site of interest is
achieved through a novel mechanism utilising a cam, a needle
funnel, two opposing ratchets, a needle and a single micromotor
manufactured by Namiki. Orientating the micromotor along the
central axis of the microrobot allows for simple coupling to the
cam and needle funnel via two opposing ratchets. Driving the
micromotor anticlockwise allows for the angular positioning of
the needle, which has been fixed at one of 16 positions equally
spaced. Driving the micromotor clockwise extends and retracts
the needle. The novel positioning mechanism functions through
the use of a series of ratchets engaging and disengaging to allow
the various operations to be performed. A detailed evaluation of
the targeting mechanism can be found in [27]. Figure 3 shows a
section view through the component parts of the needle position-
ing mechanism.
3 Drug delivery system
The drug delivery system has the capacity to store a 1 ml
volume of medication onboard the microrobot. The force
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generated by a compressed conical spring is proposed to expel
the medication. The conical spring engages with a piston and
when activated it will force the medication out of one of six-
teen preset holes at the base of the medication chamber. The
holes have a thin membrane across them to protect the integ-
rity of the medication and to prevent the medication from
leaking into the needle positioning mechanism. Rotating the
needle positioning mechanism will align a port on the back of
the needle funnel with one of the sixteen holes, the remaining
holes would automatically be blanked off and therefore pre-
vent any ingress of the medication. The novel configuration of
the conical spring provides a compact design however a trig-
gering mechanism will also be required to automatically re-
lease the spring.
The following sections discuss the design and analysis of
the drug delivery system, the trigger mechanism and the issue
of power distribution through the microrobot. A series of ex-
periments are presented which validate the drug delivery
system.
Using a compressed spring to drive the delivery of the
medication would require allocating a volume of space within
the microrobot for the spring’s solid state volume and for the
spring’s actuation mechanism. A novel way of minimising the
spring’s volume is to use a conical compression spring, Fig. 4.
Figure 4 shows a variable pitch conical compression spring
in its free state a) in the primed position b) and a plan view in
the fully coiled position c). Winding the coils such as they lie
inside each other (Fig. 4c) enables the same number of coils to
be used as in a conventional compression spring to generate a
force, however it significantly reduces the space required to
hold the spring. For example, a conical compression spring
with six Ø0.5 mm coils would occupy a solid state volume of
40.1mm3 this can be compared to a volume of 55.0 mm3 for a
conventional compression spring with the same geometry.
Providing clearance between the coils enables them to be
spiralled inside each other. A variable pitch is required be-
tween each coil to allow the spring to collapse at the same
rate, this is due to the larger coils collapsing faster than the
Fig. 1 Microrobot concept design capable of delivering 1ml of targeted medication. Needle shown fully extended and themedication partially deployed
Fig. 2 Holding mechanism
design showing: 0.2 module 13
tooth and 48 tooth bevel gears set
a) and central 0.1 module 8 tooth
spur gear is driven by the 48 teeth
bevel gear
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tighter coils. This configuration allows the active coils to bot-
tom simultaneously resulting in a straight line force versus
deflection curve similar to the output of a conventional com-
pression spring. To release the spring from the compressed
position a trigger mechanism will be required.
The conical compression spring will require analysing to de-
termine the optimummedication delivery force. Thiswill involve
analysing a number of spring variables such as the number of
coils, the diameter of the wire and the force required to operate
the system. All these factors will influence each other’s perfor-
mance and a balance will need to be determined which will
minimise the space required to house the system.
3.1 Medication delivery
To deliver a 1 ml volume of medication to a target site requires
the onboard supply of medication to be pushed through a
series of holes allowing it to be expelled through the needle
tip. To achieve this task an evaluation of the force required to
expel the medication must be performed. The bore of the
needle is the most restrictive section of the delivery system
for the flow ofmedication. The needle has an internal diameter
of 0.38 mm and a length of 6.7 mm. As the needle has a
consistent diameter and length Poiseuille’s equation can be
used to model the flow of medication through the needle.
The assumptions which will be made with Poiseuille’s equa-
tion are that the medication is incompressible and Newtonian,
the flow is laminar and friction will be ignored [28].





Where r is the radius of the needle’s bore, nv is the viscosity
of the medication and l is the length of the needle. P1 is the
pressure at the end of the needle and P2 is the pressure re-
quired to expel the medication. For the purpose of analysis the
viscosity of the medication will be based on water at 36 °C
(0.705 × 10−3 Pa s). P1 is the pressure resistance of the med-
ication being introduced into the GI tract wall. The interstitial
hydrostatic pressure in subcutaneous tissue can range from -
8 mmHg to +6 mmHg for normal tissue however for tissue
with a tumour the pressure can be much greater. Therefore P1
will be taken as the subcutaneous pressure in a tumour which
is approximately +20 mmHg (2.6 kPa) [29].
As the medication must be absorbed by the subcutaneous
tissue a delivery time has been set at 3.5 s. The flow rate (Qf )
can be calculated by dividing the 1 ml volume of medication
stored onboard the microrobot by the target delivery time (3.5 s).
Rearranging equation (1) allows the pressure difference Δ
P to be calculated (2.6 kPa). As the pressure difference
ΔP=P2−P1 the pressure required to deliver the medication
in 3.5 s P2ð Þ can be determined, 5.2kPa. The delivery pressure
P2ð Þ multiplied by the area of the medication chamber’s
plunger gives the delivery force required to expel the medica-
tion. The force applied to the medication chamber’s plunger
equates to 0.43 N.
The flow of the medication through the needle was as-
sumed to be laminar however to confirm this the Reynolds
number can be used to determine how the medication flow is
acting:
Re ¼ ρdvnv ð2Þ
Where ρ is the density of the medication, d is the diameter
of the needle, v is the velocity of the medication and nv is the
viscosity of the medication.
The Reynolds number for the system equates to approxi-
mately 1.9. For Re < 2100 the flow is laminar and for Re >
4000 the flow is turbulent. A Reynolds number between these
Fig. 3 Section view through the component parts of the needle
positioning mechanism. Material removed for clarity and needle shown
fully extended
Fig. 4 Conical compression spring configurations, 7.5 coils fully expanded with a variable pitch a) collapsed section view b) and fully coiled position c)
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two limits results in transition flows which can either be lam-
inar or turbulent. The low Reynolds number confirms the flow
will be laminar and therefore no compensation for changes in
pressure will be required.
There are a number of variables which can affect the deliv-
ery time, for example if the viscosity of the medication were to
increase it would slow the delivery speed while an increase in
temperature would speed up the delivery time.
3.2 Spring design analysis
The geometry of the microrobot places limits on the allowable
design parameters which can be used in the design of a conical
spring. However the spring must be designed to fit within a
volume of 40.0 mm3 and deliver a force of 0.43 N over a
stroke of 12.0 mm. As the spring’s deliverable force is known
the spring’s deflection f can be calculated by the following
formula for conical compression springs:







Where n is the number of active coils, r0 is the mean coil
radius of the first coil and r1 is the mean coil radius of the last
coil, Fd is the force, d is thewire diameter andG is themodule of
rigidity. A stainless steel wire spring with a module of rigidity
value of 69.0GNm−2 [30] will be used for the spring analysis.
Using an input force of 0.43 N and a combination of
0.25 mm diameter wire, 7.5 active coils, a mean coil radius of
2.1 mm for the first coil and a mean coil radius of 5.0 mm for
the final coil results in a spring with a free length deflection of
49.7 mm and which only occupies a volume of 17.9mm3.
However equation (3) calculates the deflection (f) based on a
solid length of n d whereas the compact design of the conical
spring requires the spring wires to be coiled inside each other,
this will result in a greater deflection length and therefore an
increase in the initial starting load. As the deflection is known
the new starting load Fc can be calculated as follows:
Fc ¼ Fdf ndð Þ−d þ fð Þ ð4Þ
The increased spring deflection results in a new starting
force Fcð Þ of 0.59 N however at the end of the 12.0mm stroke
length the conical spring will be delivering 0.43 N. The de-
flection force can be used to determine the stress (τ) in the






The 0.59 N force which is generated by the spring at the
start of the stroke results in 915.2MNm−2 of stress induced in
the compressed spring. The requirement for the spring is for a
single operation therefore the maximum allowable static
stresses would be limited to 59 % of the material’s ultimate
tensile strength (2,200MNm−2) [31]. The resulting stress in
the spring represents 41.6 % of the allowable static stress
therefore the variable pitch conical compression spring design
will be acceptable for the application.
3.3 Trigger mechanism
To deliver the 1 ml volume of medication a trigger mechanism
is required to release the compressed conical spring. Releasing
the spring remotely at the required moment in time is a chal-
lenging requirement. The system chosen to release the spring
is a thermo mechanical method. This method of triggering the
spring relies on the Joule’s effect to heat an igniter which in
turn ignites a pyrogen that melts a Nylon wire. The Nylon wire
is employed to retain the compressed coiled spring. Figure 5
shows a layout of the proposed system.
Figure 5 shows a section view through the thermo mechan-
ical trigger mechanism. The trigger mechanism utilises a
Nylon wire to retain the medication chamber piston (Fig. 1)
which in turn traps the conical spring, preventing it from
expanding. The medication chamber piston has two protru-
sions which pass through the trigger board. The trigger board
connects the power supply section to the main body of the
microrobot. The protrusions have been designed with two
perpendicular tapered slots. The tapers in the slots retain the
Nylon wire when it is manually wrapped around the protru-
sions. The Nylon wire passes over the igniter and propellant.
A heat shield is placed over the top of the Nylon wire and it
also encompasses the protrusions. The heat shield is retained
by two vertical armsmounted on the trigger board to prevent it
from separating at the point of ignition. Once the thermo me-
chanical mechanism has been fired the medication piston will
be propelled towards the front of the microrobot, this action
will simultaneously suck the exhaust fumes and heat from the
propellant into the medication chamber, therefore dissipating
any heat generated and preventing heat radiating into the pow-
er supply area.
The compressed conical spring will be delivering a load of
0.59 N at maximum compression therefore the Nylon wire
must be capable of holding this force without breaking pre-
maturely or elongating under the strain and partially deliver-
ing the medication. A Nylon monofilament wire has been
selected which melts at 220 °C, has a Young’s modulus of 3,
300MNm−2 and a diameter of 0.10 mm. The technology cho-
sen to ignite the propellant, which in turn will melt the Nylon
wire, is an electro-pyrotechnic initiator thin film chip (EPIC)
(Vishay Intertechnology, Inc.). The microjoule energy device
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is a surface mount device (SMD) (size 0603) comprising a
ceramic (alumina) based substrate with a tantalum nitrogen
(Ta2N) deposit as the activating resistor. A propellant, which
ignites at 456.8 °C [32], is applied to the EPIC igniter.
The resistance Rtnð Þ of the tantalum nitrogen heating
element is dependent on the resistivity of the material
and the geometry of the element. It can be calculated as
follows:
Rtn ¼ rtnlwt ð6Þ
Where rtn is the resistivity of the tantalum nitrogen material
(400μΩ x cm), l is the length of the heating element, w is the
width and t is the material’s thickness.
Using the geometry of 75 μm for the length (l), 50 μm for
the width (w) and 2 μm for the thickness (t) results in a heating
element resistance Rtnð Þ of 3.0Ω. The electrical energy (Ei)
required to ignite the propellant and melt the Nylon wire can
be calculated by the following formula:
Ei ¼ lwtρCpΔT ð7Þ
Where l is the length of the heating element,w is the width,
t is the material’s thickness, ρ is the density of tantalum nitro-
gen (11.5 gcm3), Cp is the specific heat of the material
(0.14 J g−1 °C−1) andΔT is the adiabatic temperature required
at the heating element.
Using equation (7) with the heating element geometry al-
ready specified and an ignition temperature ΔTð Þ of 456.8 °C
results in an electrical energy of 5.5 μJ required to ignite the
propellant. However a safety factor is required to ensure that
the electrical pulse delivered to the EPIC device is sufficient to
ignite the propellant therefore a safety factor of 10 will be
applied. Incorporating the safety factor into equation (7)
results in 55μJ of electrical energy required to ignite the boron
potassium nitrate propellant.
The firing time Ftð Þ required to ignite the propellant can be




Where Ei is the electrical energy required to ignite the
propellant, Rtn is the resistance of the heating element and I2
is the supply current.
Using equation (8) with a supply current of 0.5 A results in
a firing time of 74 μs. Increasing or decreasing the current will
affect the firing time. However the combination of the heating
element geometry and the supply current must be chosen to
guarantee the device does not fire through external influences,
such as electro-magnetic interference from the environment,
and can only be fired by the activation energy pulse.
3.4 Electronics
The microrobot presents a number of challenges to realising a
system which can perform targeted drug delivery as limita-
tions on space restrict the use of components, however
the various electronic components and wiring must be
considered. The key electronic components will include
the following:
CMOS Image Sensor: This design uses a commercially
available subminiature image sensor manufactured by
Toshiba (TCM8230MDA) with four white SMT LEDs
manufactured by Agilent (HSMW-C191) integrated on a
PCB.
Controller ASIC: The power management (i.e., dc/dc conver-
sion), telemetry, timing and control are being implemented in a
full-custom ASIC in a commercially available 0.18 μm CMOS
Fig. 5 Cut-through view of the
thermo mechanical trigger
mechanism. Heat shield shown
suspended above the igniter and
Nylon wire
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technology. Much of the specific circuit implementations will be
based on previously reported systems [33–35].
System Wiring: The increased functionality the mecha-
nisms bring to the microrobot present the challenge of supply-
ing power to the actuators performing the various operations.
A circuit schematic of the power distribution for the
microrobot is presented in Fig. 6.
Figure 6 highlights the requirement for multiple connec-
tions to pass through the forward, middle and rear sections
of the microrobot. A more precise evaluation shows that the
microrobot can be split into five distinct sections which all
have a demand for power:
& The visualisation and processing section
& The holding mechanism
& The needle positioning mechanism
& The medication delivery system
& The power supply section
The configuration of the five sections of the microrobot
presents problems of power delivery through the device, spe-
cifically delivering power to the holding mechanism and the
visualisation and processing sections. This is due to the
requirement that the holding mechanism can be deployed
diametrically opposite the needle. This feature requires the
front section of the microrobot to rotate 360° relative to
the rear section. It is assumed that the rear section will
remain static due to the mass of the medication and power
supply and also from the pressure generated by the GI
tract wall. The needle positioning mechanism and the
medication delivery system have direct access to the pow-
er supply, however the medication chamber and the
micromotor driving the needle positioning mechanism in-
hibit the direct passage of power to the front of the
microrobot. Figure 7 highlights the five sections with a
cut-through view of the microrobot.
To overcome the issue of power distribution through the
microrobot and to control the angular orientation of the needle
positioning mechanism a specifically designed rotary encoder
is proposed.
3.4.1 Rotary encoder
A specifically designed rotary encoder mounted between the
medication chamber and the needle positioning mechanism is
the proposed solution for providing power through the for-
ward section of the microrobot, Fig. 8. The rotary encoder
uses flexible PCB cabling, which adheres to the outside of
the microrobot’s body, to connect the power supply at the rear
of the microrobot to the rotary encoder board. Utilising the
outside of the microrobot bypasses the need to disrupt the
medication compartment making sealing the medication
chamber more straightforward.
The rotary encoder board, which is 0.5 mm thick, allows
power to be supplied to the visualisation and processing sec-
tion and to the holding mechanism while the front of the
microrobot is rotating. The rotary encoder achieves this
through four 0.3 mm wide concentric tracks which have been
positioned to take into consideration the limitations of flexible
PCB manufacture and also to accommodate the holes which
allow the medication to pass through the board and into the
needle funnel, (Fig. 8a). Contact pins held in the needle posi-
tioning mechanismmake contact with the tracks however they
remain free to rotate with the needle funnel. A fifth contact pin
is mounted in the needle funnel and used in conjunction with a
registration contact on the rotary encoder board to determine
the angular position of the needle and holding mechanism,
(Fig. 8b).
The contact pins align with pads on a flexible PCB board
which is incorporated into the needle funnel. The pins stand
proud of the needle funnel by 0.05 mm to ensure they make
contact with the tracks on the rotary encoder board. The flex-
ible PCB passes through the needle funnel and through the
retaining plate.
The shape of the distal end of the holding mechanism’s legs
have been designed to accommodate the flexible cable, how-
ever the cable cannot pass through the bevel gear set which is
positioned behind the holding mechanism’s legs as it will be
rotating. Therefore the power supply is again routed out
through the side of the microrobot and then back into the
space behind the bevel gear set where it can supply power to
Fig. 6 Circuit schematic of the
power supply requirement for the
microrobot
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the visualisation and processing section and to the holding
mechanism.
The power supply for the forward section is supplied
through the onboard battery which is stored at the rear section
of the microrobot. As specified the rotary encoder’s flexible
PCB board adheres to the outside of the microrobot’s body
and connects to the power supply, however the power supply
is required to be removable to allow access to the medication
chamber for loading.
3.4.2 Power supply
A compact method of connecting the power supply to the
microrobot is required which will allow access to the medica-
tion chamber for filling and also connect with the flexible
PCB board which links to the rotary encoder. Figure 9 shows
the chosen design in three stages of assembly.
Figure 9 shows the proposed assembly of the power supply
unit. The solution is a modular system which allows the med-
ication chamber to be manually loaded and also provides a
method of connecting to the rotary encoder PCB board run-
ning on the outside of the body. The solution incorporates a
flexible PCB board which wraps around a silver oxide button
cell battery (CR1025 Energizer), (Fig. 9a). The battery and
flexible PCB board are secured into a cap with resin to ensure
the unit cannot be damaged. A contact board is also secured
into the side of the cap which facilitates the connection to the
rotary encoder PCB board, (Fig. 9b). The cap and battery are
fitted to the trigger mechanism via a snap fit on the trigger
board, (Fig. 9c). The assembly can be loaded onto the
microrobot’s body via a central lug protruding from the trigger
board. The lug secures the power supply unit and also con-
nects the power supply to the micromotor and to the EPIC
device. The flexible PCB board running on the outside of
the body is connected to the contact board to complete the
connection with the front of microrobot.
The proposed solution allows the medication chamber to
bemanually filled at the point just prior to administration. This
feature gives flexibility in the choice of medication which can
be prescribed to the patient therefore potentially broadening
the scope of its use.
3.4.3 Energy requirements
The design of the modular battery unit allows power to be
supplied to the mechanisms of the microrobot. As the onboard
Fig. 7 Cut-through view of the
microrobot with the five main
sections labelled
Fig. 8 Rotary encoder:
concentric tracks and registration
contact (a) and contact pins
embedded in the needle funnel (b)
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space to hold the power supply is limited a review of the power
consumption of the various mechanical mechanisms has been
performed. The energy required to operate the triggermechanism
is very low at only 55 μJ however the energy required to operate
the needle positioning mechanism and the holding mechanism is
much greater. The energy required to operate the twomechanism
has been estimated from the peak current consumption of the
Namiki motor controller (SSD04) and the Faulhaber motor con-
troller (BLD05002S), which are stated as 800 mA at 6 V and
400 mA at 7.5 V. Three revolutions of the Namiki micromotor
are required for positioning and deployment of the needle; this is
achieved in 3.8 s, while the holding mechanism can complete a
full opening and closing cycle in 1.78 s. Using a Lithium coin
battery with a volume of 188mm3 and an energy density of
435 Wh/L (CR1025 Energizer), the mechanisms will consume
at most 28.94 J of energy for each complete cycle which is only
9.83 % of the available energy, offering the potential for multiple
operations.
4 Measurement and characterisation
of the medication delivery mechanism
This section presents a series of experiments designed to val-
idate the medication delivery system. The experiments focus
on determining the parameters required for the delivery of the
medication and on the performance of the conical compres-
sion spring through quantitative assessment of a 1:1 scale
model prototype manufactured from stainless steel (BS 2056
Austenitic 302).
4.1 Medication delivery performance protocol
The purpose of the medication performance experiment is to
determine if the chosen delivery speed of 3.5 s is suitable to
expel the 1 ml of onboard medication. The analysis performed
in Section 3.1 (Eq. 1) was based on water at body temperature
(36 °C) however ex vivo experiments will be performed at
room temperature therefore the viscosity of the water will
increase to 1 × 10−3 Pa s to compensate. The implication of
this change will be a reduction in delivery speed to 5 s to
maintain the calculated delivery force.
The test set-up used to measure the delivery force required
to expel the 1 ml of medication is presented in (Fig. 10a). A
specially designed plunger has been produced which can be
used with a conventional syringe body. The plunger is inde-
pendent of the loadcell adaptor and any sideways movement
between the plunger and body has been minimised for the
purpose of reducing friction within the system. The reduction
in friction will result in a consistent force being generated by
the plunger assembly.
The mathematical model (Eq. 1) presented for calculating
the force required to deliver the medication assumed a straight
through needle orientation and presented no difference be-
tween a vertical and horizontal configuration due to the
Reynolds number being very low, however comparing the
flow of a liquid in the vertical configuration (Fig. 10b) with
the flow of liquid in the horizontal configuration (Fig. 10c)
will prove the validity of this hypothesis.
4.1.1 Medication delivery procedure
Figure 10a shows the test set-up used to determine the force
required to deliver a 1 ml volume of water. The body of a
2.5 ml capacity syringe (300,185, BD Plastipak) is securely held
in a fixture. The bore of the syringe (Ø8.60 mm) is used to
calculate the linear movement of the plunger (17.2 mm) required
to deliver 1 ml volume of liquid. A 5 N loadcell (Intelligent
loadcell ILC 879–010, ±0.1 % of full scale) is fitted to the linear
actuator of aMultiTest 2.5-i (805–102) test systemmanufactured
by Mecmesin to measure the load required for a delivery. The
loadcell has been programmed to travel at the required delivery
speed of 207 mm/min for a distance of 17.20 mm from the tared
zero position. A computer running Emperor™ (force) software
(v. 1.18–408 (5/10/13)) is connected to theMultiTest system and
used to record the delivery data.
The delivery program will be run multiple times with no
liquid being delivered and the data for each run recorded. The
Fig. 9 Power supply assembly:
flexible PCB board wrapped
around the battery (a) battery and
flexible PCB board secured into
the cap with contacts aligned (b)
and trigger mechanism and power
supply assembly ready to be
loaded into the microrobot’s body
(c)
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results of the average delivery force will be combined and the
average of these runs will be used to calculate the friction in the
system due to the seal on the plunger. The syringe will be filled
with water and a piece of chicken breast flesh positioned such as
the needle tip is embedded into the chicken by approximately
1.5 mm. Chicken breast flesh has been chosen as it has signifi-
cant similarities to the tissue of the GI tract wall [36]. The deliv-
ery programwill be run multiple times with the data for each run
recorded. The results of the average delivery force will be com-
bined and the average of these runs will be used to calculate the
delivery force required to deliver the 1 ml volume of water.
4.1.2 Results and discussion
Measurement of the force required to operate the plunger assem-
bly with the luer lock and needle fitted were first taken to estab-
lish a baseline friction force for the plunger assembly. Due to the
sensitivity of the measuring system and the variability of the
results a large number of deliveries were performed. Over a set
of 30 runs the average delivery force for a dry delivery was
2.3 N.
A series of deliveries were performed which expelled a
1 ml volume of water with the needle orientated in the vertical
configuration and also with the needle orientated in the hori-
zontal configuration, as this would more closely match the
needle orientation in the microrobot. The needle configura-
tions can be seen in Fig. 11.
The average delivery force for a 1ml volume of water over 10
runs for the vertical configuration was 2.75 N, this can be com-
pared to the average delivery force for the same volume of water
over 10 runs for the horizontal configuration which was 2.73 N.
The results show that the average horizontal delivery
force is lower than the vertical delivery force. The small
difference in delivery force (17.0mN) can be attributed
to the sensitivity of the test method. However the re-
sults confirm that there is very little turbulence in the
system and hence confirms the low Reynolds number
and that the flow will be laminar.
A series of deliveries were performed which expelled a 1 ml
volume of water into chicken breast flesh to simulate the intesti-
nal pressure at the end of the needle tip. The needle was orien-
tated in the vertical configuration as it guaranteed needle pene-
tration and prevented the chicken breast flesh from being pushed
away from the needle due to the pressure of the delivery force.
The set-up used to measure the delivery force can be seen in
Fig. 12.
An overlay of the measured load profiles for three deliver-
ies of a 1 ml volume of water into chicken breast flesh can be
seen in Fig. 13. The average delivery force required to expel
the volume of water was 2.95 N with a standard deviation
from the mean of 40mN. However subtracting the baseline
friction force for a dry delivery of 2.32 N from the delivery
force results in a delivery force of 0.63 N. This figure is very
close to the calculated figure of 0.59 N.
Fig. 10 Layout of the medication
performance delivery test fixture
(a) vertical needle configuration
(b) and horizontal needle
configuration (c)
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The test result plots highlight the behaviour of the delivery
method, for example a spike of 4.0 N can be seen in sample 3
at the beginning of the delivery (Fig. 13). The spike can be
attributed to the build-up of liquid due to the chicken breast
flesh not absorbing the water quickly enough and hence caus-
ing a back pressure. The measured data suggests that the de-
livery speed of 5 s should be increased to allow the medication
to penetrate and be absorbed by the tissue however this is
based on the behaviour of chicken breast flesh at room tem-
perature and in vivo tests would need to be performed to
validate the actual figures.
4.2 Spring deflection protocol
To deliver the medication in 5 s the variable pitch conical
compression spring must be capable of providing the calcu-
lated force of 0.59 N at the start of the delivery. Therefore the
design of the spring must be validated to ensure its suitability
to perform the task. There are no British Standards or industry
standards for the design of conical compression springs how-
ever The Institute of Spring Technology (IST) provides a soft-
ware package which is based on theoretical mathematical
models and empirical data to aid in the design and analysis
of conical compression springs and also to determine their
suitability for manufacture. The IST software will be used to
verify the calculations derived in Section 3.2.
The space available onboard the microrobot to house the
spring has changed due to the requirements imposed by the
trigger mechanism therefore the spring parameters will be
modified from those used on the theoretical mathematical
model (Eq. 4) to accommodate the available space. Using
the IST spring calculator professional software (v1.0.18) a
prototype 1:1 scale variable pitch conical compression spring
will be designed and evaluated for its suitability to deliver the
Fig. 11 Left: Vertical needle
configuration; Right: Horizontal
needle configuration
Fig. 12 Left: Medication
delivery force experimental set-up
comprising: a 2.5 ml syringe body
mounted on a block, the
Ø0.38 mm bore needle fitted to
the syringe and a MultiTest 2.5-i
test system fitted with a 5 N
loadcell and connected to a
computer running Emperor™
(force) software; Right: Needle
delivering liquid into a chicken
breast test piece
30 J Micro-Bio Robot (2016) 11:19–34
required starting load and also to perform within acceptable
stress levels (59 % of UTS).
A stainless steel wire spring (BS 2056 Austenitic 302S26
G2) with a module of rigidity value of 70.3GNm−2 has been
selected for the prototype spring. The 0.25 mm diameter wire
has 7.5 active coils, 2 dead coils for the purpose of stabilising
the spring during operation, a mean coil radius of 2.6 mm for
the first coil and a mean coil radius of 5.12 mm for the final
coil and a free length of 48.8 mm. The modified spring pa-
rameters result in a linear spring rate of 10.9mN/mm which
equates to a theoretical solid state load of 0.53 N however the
software predicts a solid state load of 0.79 N and a solid state
stress of 991.0Nmm−2 (45 % of UTS). The discrepancy in
load can be attributed to one of the coils prematurely touching
at the final stage of compression, this will result in the coil
collapsing which in turn will increase the spring rate. However
it is anticipated that manual modification of the spring end will
eliminate this issue and result in the calculated load (0.53 N).
4.2.1 Spring deflection procedure
The stainless steel conical compression spring will be mounted
on a mandrel and held between two supports which have been
designed to hold the end coils in position while the spring
collapses. The test set-up used to measure the force delivered
by the compression of the conical spring is presented in Fig. 14.
The springwill be tested on aMultiTest 2.5-imanufactured by
Mecmesin. A 2 N loadcell (Intelligent loadcell ILC 879–009,
±0.1 % of full scale) will measure the load generated by the
compression of the spring from its free state to its solid state.
The testwill be run at a velocity of 145.0mm/minwhichmatches
the calculated delivery speed. The compression program will be
run multiple times with the data for each run recorded. The
results of the average peak force at solid state will be combined
and the average of these runs will be used to calculate the deliv-
ery force. A further measurement at 12.0 mm deflection will be
recorded and the average force from the deliveries will be used to
determine the spring’s force at the end of its stroke.
4.2.2 Results and discussion
A total of 10 springs were dimensionally inspected on a digital
vision measuring system (TESAVision 200, TESATechnology
Fig. 13 Overlay of three plots of the measured delivery force required to deliver a 1 ml volume of water into chicken breast flesh
Fig. 14 Variable pitch conical compression spring deflection load test
fixture
Fig. 15 1:1 scale prototype stainless steel variable pitch conical
compression spring
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UK Ltd.) with the results showing that the 2.6 mm mean coil
radius for the first coil was outside of the design specification at
2.76 mm and the springs’ free length was 47.7 mm compared to
the design value of 48.84 mm. The reduced clearance between
the coils due to the larger radius of the first coil resulted in the
coils touching during the final stages of compression. The coils
could not be manually modified to reinstate the clearance as
initially anticipated therefore the springs were tested through a
stroke length of 46.65 mm to minimise the impact of the coils
colliding. Figure 15 shows the conical compression spring in its
free state.
The test jig was configured such that the mandrel could
pass freely in and out of the loadcell adaptor without generat-
ing a false reading on the loadcell due to friction. A 0.5 mm by
10.3 mm diameter counter bore was positioned in the loadcell
adaptor support to accommodate the large coil and to prevent
it from moving during compression. The 0.5 mm depth of the
bore allowed clearance for the coils at the end of the stroke.
Figure 16 shows the test set-up used to hold the spring verti-
cally between two supports and via a central mandrel. The
spring is also shown in the fully compressed configuration.
A total of 10 springs were compressed 10 times each from a
preloaded compression of 0.2 mm through a stroke length of
46.45 mm to give a total working compression of 46.65 mm.
The stroke length allowed 1.05 mm of clearance at the end of
the stroke for the solid state of the spring. The springs were
preloaded to stabilise the coils during the compression se-
quence and to accommodate slight variations in the overall
length of the spring. A typical load profile of a spring com-
pression can be seen in Fig. 17.
Figure 17 shows a peak load of 0.94 N at the end of the
stroke. As the coils could not be modified manually to elim-
inate touching during the compression the measured result can
be compared to the calculated figure of 0.79 N. The higher
result can be directly attributed to the coils contacting each
other and increasing the spring rate. Figure 17 highlights the
change in spring rate through the compression sequence.
Between zero and 30.0 mm the spring rate is
10.93mN/mm resulting in a peak load of 0.32 N and
between 30.0 mm and 46.45 mm the spring rate signif-
icantly increases to 37.60mN/mm, resulting in the peak
load of 0.94 N. The results for the series of tests show
that the springs are consistent with an average spring
rate of 10.97mN/mm for compression up to 30.0 mm
and 32.8mN/mm up to 46.45 mm. The abrupt changes
in load which are evident at 41.85 mm and 46.1 mm
are due to the coils slipping over each other.
It is a requirement that the spring can deliver a force of
0.43 N at the end of its 12.0 mm stroke to guarantee delivery
of the medication in 5 s. It can be seen in Fig. 17 that a load of
0.42 N is developed at 35.65 mm compression which repre-
sents the end position of the piston (12.0 mm). The results of
the protocol show that the conical compression spring will
deliver sufficient force to expel the medication in 5 s and that
the stress in the spring will be at a safe level as the overall
length of the springs remained the same after repeated opera-
tions. The performance of the spring could benefit from some
improvements. For example, generally increasing the clear-
ance between the coils, reducing the number of coils and in-
creasing the wire diameter would result in a more stable spring
which would deliver a consistent load and have lower levels of
stress. However the deliverable force at the end of the
Fig. 16 Left: Conical spring held vertically between two supports and
further supported via a mandrel; Right: Spring in the fully compressed
configuration
Fig. 17 Load profile of a typical spring compression
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12.0 mm stroke would drop off slightly resulting in a longer
delivery time.
5 Conclusion
In this paper we have presented the first WCE with increased
functionality to allow targeted drug delivery to be performed
in the small intestinal tract. A novel drug delivery system has
been proposed which delivers 1 ml of medication and only
occupies a volume of 65.0 mm3.
It has been shown through analysis and experimentation
that a stainless steel variable pitch conical compression spring
can be wound such that it has a solid state thickness of the wire
diameter and occupies a volume of 17.9mm3. The conical
spring is capable of delivering a force of 0.59 N at the solid
state and a force of 0.43 N at the end of the 12.0 mm stroke
which is sufficient force to expel the 1 ml of onboard medica-
tion in the required delivery time of 5 s.
The presented solution for targeted drug delivery combines
a holding mechanism capable of resisting peristalsis, a
targeting mechanism capable of positioning a needle within
a 360 degree envelope and a medication delivery system and
integrates them into a conventional wireless capsule endo-
scope. The combined mechanisms only occupy 75 % of the
available volume including the 1 ml of medication and the
power supply.
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